US 11,957,884 B2
Insulin injection assistance systems, methods, and devices
John Sjolund, Los Altos, CA (US); Ambika Srinath, San Francisco, CA (US); Andrew Bochenko, Redwood City, CA (US); George Crothall, Oceanside, CA (US); Bryan Mazlish, Palo Alto, CA (US); Jennifer Martin Block, Menlo Park, CA (US); Sarah Matarese, San Jose, CA (US); Linda Mackowiak, Cazenovia, NY (US); and Lane Desborough, Thousand Oaks, CA (US)
Assigned to Bigfoot Biomedical, Inc., Milpitas, CA (US)
Filed by Bigfoot Biomedical, Inc., Milpitas, CA (US)
Filed on Jul. 29, 2021, as Appl. No. 17/444,007.
Application 17/444,007 is a continuation of application No. 16/218,212, filed on Dec. 12, 2018, granted, now 11,083,852.
Claims priority of provisional application 62/682,878, filed on Jun. 9, 2018.
Claims priority of provisional application 62/628,808, filed on Feb. 9, 2018.
Claims priority of provisional application 62/597,809, filed on Dec. 12, 2017.
Claims priority of provisional application 62/597,868, filed on Dec. 12, 2017.
Prior Publication US 2021/0386936 A1, Dec. 16, 2021
Int. Cl. A61M 5/315 (2006.01); A61B 5/145 (2006.01); A61K 38/28 (2006.01); A61M 5/20 (2006.01); A61M 5/32 (2006.01); G16H 20/13 (2018.01); A61B 5/00 (2006.01); A61M 5/31 (2006.01); G16H 50/20 (2018.01)
CPC A61M 5/31546 (2013.01) [A61B 5/14532 (2013.01); A61K 38/28 (2013.01); A61M 5/20 (2013.01); A61M 5/3202 (2013.01); G16H 20/13 (2018.01); A61B 5/4839 (2013.01); A61B 5/681 (2013.01); A61M 2005/3125 (2013.01); A61M 2205/18 (2013.01); A61M 2205/3561 (2013.01); A61M 2205/3584 (2013.01); A61M 2205/505 (2013.01); A61M 2205/581 (2013.01); A61M 2205/582 (2013.01); A61M 2205/583 (2013.01); A61M 2209/06 (2013.01); A61M 2230/201 (2013.01); G16H 50/20 (2018.01)] 20 Claims
OG exemplary drawing
 
1. A method of assisted manual dosing of insulin, the method comprising:
receiving first insulin delivery events associated with a first insulin manual delivery assembly, the first insulin manual delivery assembly comprising a first reusable insulin dosing detector reversibly connected to a first disposable component and configured to detect the first insulin delivery events;
determining first timing data corresponding to one or more first insulin delivery event times of one or more of the first insulin delivery events;
analyzing glucose data in combination with the first timing data; and
determining an adjustment recommendation responsive to the analysis of the glucose data and the first timing data.